Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Hypothyroidism II: Pathophysiology

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

Graves' Disease I: Introduction

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

Goiter

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Antithyroid drug treatment in pregnancy: A first report from the Danish PRETHYR multicenter study.

The Journal of clinical endocrinology and metabolism·2026

Same author

Selenium supplementation in individuals with newly diagnosed Graves' hyperthyroidism: a double-blind, multi-centre RCT.

European thyroid journal·2025

Same author

Genome-wide association study and polygenic risk prediction of hypothyroidism.

Nature genetics·2025

Same author

Canadian Endocrinologists' Perspectives on Treatment With Thyroid Hormone Substitutions in Euthyroid and Hypothyroid Patients: A 2023 THESIS Questionnaire Survey.

Clinical endocrinology·2025

Same author

Long-term outcomes of LT4/LT3 combination treatment for persistent hypothyroid symptoms.

European thyroid journal·2025

Same author

Thyroid dysfunction and exudative age-related macular degeneration - A longitudinal nationwide registry-based cohort study.

Acta ophthalmologica·2024

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

Hyperthyroidism (primary).

Birte Nygaard¹

¹Department of Endocrinology, Herlev Hospital, University of Copenhagen, Herlev Ringvej, Copenhagen, Denmark.

BMJ Clinical Evidence

|May 20, 2009

Summary

This summary is machine-generated.

This systematic review evaluates drug and surgical treatments for hyperthyroidism. It found evidence on antithyroid drugs, radioactive iodine, and thyroidectomy for effectiveness and safety.

Related Experiment Videos

Last Updated: Jun 23, 2026

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

Area of Science:

Endocrinology
Internal Medicine
Pharmacology

Background:

Hyperthyroidism involves elevated thyroxine and triiodothyronine with suppressed thyroid-stimulating hormone.
Graves' disease, toxic multinodular goitre, and toxic adenoma are primary causes.
Hyperthyroidism affects women approximately 20 times more frequently than men.

Purpose of the Study:

To systematically review the effects of drug and surgical treatments for primary hyperthyroidism.
To assess the impact of interventions for subclinical hyperthyroidism.
To evaluate the safety and effectiveness of various hyperthyroidism therapies.

Main Methods:

Systematic review of medical literature.
Searched Medline, Embase, and The Cochrane Library up to June 2007.
Included harms alerts from regulatory agencies like the FDA and MHRA.

Main Results:

14 systematic reviews, RCTs, and observational studies were included.
GRADE methodology was used to evaluate evidence quality.
Information on intervention effectiveness and safety was compiled.

Conclusions:

The review presents data on antithyroid drugs (carbimazole, propylthiouracil, thiamazole).
Effectiveness and safety of radioactive iodine and thyroidectomy are discussed.
The study also covers adding thyroxine to antithyroid drug regimens.